Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 11, 2011 - Issue 3
Submit an article Journal homepage
380
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Interferon in the treatment of chronic hepatitis C: a drug caught between past and future

Elena Vezali A.M. Migliavacca Center for Liver Disease, First Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli studi di Milano, Via F. Sforza 35, 20122 Milan, Italy +39 0255 035432; +39 0250320410; [email protected]; Hygeia Diagnostic and Therapeutic Center of Athens, Athens, Greece
,
Alessio Aghemo A.M. Migliavacca Center for Liver Disease, First Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli studi di Milano, Via F. Sforza 35, 20122 Milan, Italy +39 0255 035432; +39 0250320410; [email protected]
&
Massimo Colombo A.M. Migliavacca Center for Liver Disease, First Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli studi di Milano, Via F. Sforza 35, 20122 Milan, Italy +39 0255 035432; +39 0250320410; [email protected]
Pages 301-313 | Published online: 21 Jan 2011

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, Pietro Lampertico & Massimo Colombo. (2013) PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history. Expert Review of Anti-infective Therapy 11:5, pages 459-474.
Read now
Farzin Roohvand & Niloufar Kossari. (2012) Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities. Expert Opinion on Therapeutic Patents 22:4, pages 391-415.
Read now
Mauro Viganò, Elisabetta Degasperi, Alessio Aghemo, Pietro Lampertico & Massimo Colombo. (2012) Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management. Expert Opinion on Biological Therapy 12:2, pages 193-207.
Read now

Articles from other publishers (11)

Takaki Nakajima, Kazuya Nagano, Yuka Fukuda, Yu Ishima, Hiroko Shibata, Ryo Isaka, Tian-qi Zhang, Yuya Haga, Kazuma Higashisaka, Hirofumi Tsujino, Tatsuhiro Ishida, Akiko Ishii-Watabe & Yasuo Tsutsumi. (2022) Subvisible Particles Derived by Dropping Stress Enhance Anti-PEG Antibody Production and Clearance of PEGylated Proteins in Mice. Journal of Pharmaceutical Sciences 111:5, pages 1363-1369.
Crossref
Saad Tayyab & Shevin Rizal Feroz. 2021. 193 218 .
Harry L.A. Janssen, Maurizia R. Brunetto, Yoon Jun Kim, Carlo Ferrari, Benedetta Massetto, Anh-Hoa Nguyen, Adarsh Joshi, Jacky Woo, Audrey H. Lau, Anuj Gaggar, G. Mani Subramanian, Eric M. Yoshida, Sang Hoon Ahn, Naoky C.S. Tsai, Scott Fung & Edward J. Gane. (2018) Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. Journal of Hepatology 68:3, pages 431-440.
Crossref
Ahmed Lasfar, Helen Gogas, Andrew Zloza, Howard L Kaufman & John M Kirkwood. (2016) IFN-λ cancer immunotherapy: new kid on the block. Immunotherapy 8:8, pages 877-888.
Crossref
Eric Lawitz, Daniel Gruener, Thomas Marbury, John Hill, Lynn Webster, David Hassman, Anh-Hoa Nguyen, Stefan Pflanz, Erik Mogalian, Anuj Gaggar, Benedetta Massetto, G Mani Subramanian, John G McHutchison, Ira M Jacobson, Bradley Freilich & Maribel Rodriguez-Torres. (2014) Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis C. Antiviral Therapy 20:7, pages 699-708.
Crossref
Claire Ginn, Hanieh Khalili, Rebecca Lever & Steve Brocchini. (2014) PEGylation and its impact on the design of new protein-based medicines. Future Medicinal Chemistry 6:16, pages 1829-1846.
Crossref
Fan-ching Lin & Howard A. Young. (2014) Interferons: Success in anti-viral immunotherapy. Cytokine & Growth Factor Reviews 25:4, pages 369-376.
Crossref
Hawwa Alao & T. Jake Liang. (2014) Alternative interferons and immunomodulators in the treatment of hepatitis C. Liver International 34, pages 133-138.
Crossref
Monika Farys, Claire L. Ginn, George O. Badescu, Karolina Peciak, Estera M. Pawlisz, Hanieh Khalili & Steve J. Brocchini. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 52 .
Jason E. Bonner, A. Sidney BarrittIVIV, Michael W. Fried & Donna M. Evon. (2012) Tangible Resources for Preparing Patients for Antiviral Therapy for Chronic Hepatitis C. Digestive Diseases and Sciences 57:6, pages 1439-1444.
Crossref
Yoon Won Kim. (2011) The Development of Anti-inflammatory Drugs for Viral Diseases. Journal of Bacteriology and Virology 41:3, pages 209.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.